The study of effects of Probiotic lactobacilli in Preventing Major Complications in patients of Liver Cirrhosis

INTERVENTION: Intervention1: Probiotic lactobacilli: 2 Billion CFU/cap Twice daily Control Intervention1: Placebo: One Capsule twice daily CONDITION: Cirrhosis of the liver PRIMARY OUTCOME: Incidence of complications of liver cirrhosis, during the treatment period‐‐‐‐‐‐Timepoint: From beginning to end of the study SECONDARY OUTCOME: Death‐‐‐‐‐‐Timepoint: From beginning to end of the study Hospital admissions due to cirrhosis complications‐‐‐‐‐‐Timepoint: From beginning to end of the study Liver function tests‐‐‐‐‐‐Timepoint: Visit1, Visit2 and Visit3 Renal Function tests‐‐‐‐‐‐Timepoint: Visit1, Visit2 and Visit3 Serum ammonia‐‐‐‐‐‐Timepoint: Visit 1, visit 2 and visit3 INCLUSION CRITERIA: Age: 30 to 50 years Sex: both Patient with sonographically confirmed diagnosis of cirrhosis Patients with liver cirrhosis with the history of major complication of cirrhosis (including variceal bleeding, encephalopathy and spontaneous bacterial peritonitis) Evidence for portal hypertension